136
- Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. Causes and mechanisms of nondipping
hypertension. Clin Exp Hypertens. 2008;30(7):585–97. - Borrelli S, De Nicola L, Stanzione G, Conte G, Minutolo R. Resistant hypertension in nondi-
alysis chronic kidney disease. Int J Hypertens. 2013;2013:929183. - Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney
disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;4(3):656–64. - Ridao N, Luño J, García de Vinuesa S, Gómez F, Tejedor A, Valderrábano F. Prevalence of
hypertension in renal disease. Nephrol Dial Transplant. 2001;16(Suppl 1):70–3. - Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension aware-
ness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency
Cohort (CRIC) study. Am J Kidney Dis. 2010;55(3):441–51. - Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, et al. Remission of
essential hypertension after renal transplantation. N Engl J Med. 1983;309(17):1009–15. - Herrera M, Coffman TM. The kidney and hypertension: novel insights from transgenic mod-
els. Curr Opin Nephrol Hypertens. 2012;21(2):171–8. - Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary
hypertension. N Engl J Med. 2003;348(2):101–8. - Widgren BR, Herlitz H, Hedner T, Berglund G, Wikstrand J, Jonsson O, et al. Blunted renal
sodium excretion during acute saline loading in normotensive men with positive family histo-
ries of hypertension. Am J Hypertens. 1991;4(7 Pt 1):570–8. - Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, Sutherland WH, et al.
Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr. 2010;91(3):557–64. - Al-Solaiman Y, Jesri A, Zhao Y, Morrow JD, Egan BM. Low-Sodium DASH reduces oxi-
dative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens.
2009;23(12):826–35. - McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, et al. A random-
ized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013;24(12):2096–103. - Vasavada N, Agarwal R. Role of excess volume in the pathophysiology of hypertension in
chronic kidney disease. Kidney Int. 2003;64(5):1772–9. - Saad E, Charra B, Raj DS. Hypertension control with daily dialysis. Semin Dial.
2004;17(4):295–8. - Ok E, Duman S, Asci G, Tumuklu M, Onen Sertoz O, Kayikcioglu M, et al. Comparison of
4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-
controlled study. Nephrol Dial Transplant. 2011;26(4):1287–96. - Günal AI, Duman S, Ozkahya M, Töz H, Asçi G, Akçiçek F, et al. Strict volume control nor-
malizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001;37(3):588–93. - Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system:
from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev.
2007;59(3):251–87. - Weidmann P, Maxwell MH, Lupu AN, Lewin AJ, Massry SG. Plasma renin activity and blood
pressure in terminal renal failure. N Engl J Med. 1971;285(14):757–62. - Vaughan ED, Carey RM, Ayers CR, Peach MJ. Hemodialysis-resistant hypertension: control
with an orally active inhibitor of angiotensin-converting enzyme. J Clin Endocrinol Metab.
1979;48(5):869–71. - Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res. 2013;50(2):89–99.
- Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat.
J Clin Invest. 1996;98(4):1063–8. - Ibrahim HN, Hostetter TH. The renin-aldosterone axis in two models of reduced renal mass in
the rat. J Am Soc Nephrol. 1998;9(1):72–6. - Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M, et al. Renal sympa-
thetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2
Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903–9.
F. Turgut et al.